Genotypic and phenotypic differences between Arabian and Scandinavian women with gestational diabetes mellitus

Diabetologia

Volumn 47, Issue 5, 2004, Pages 878-884

  Shaat, N ^a   Ekelund, M ^a   Lernmark, A ^a,b   Ivarsson, S ^c   Nilsson, A ^a   Perfekt, R ^a   Berntorp, K ^a   Groop, L ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF WASHINGTON   (United States)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Arabian; Autoimmunity; GAD65ab; Gestational diabetes mellitus; HLA DQB1; INS VNTR; Insulin resistance; mtDNA; PPAR 2; Scandinavian

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; ALLELE; ARAB; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; PHENOTYPE; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; SCANDINAVIA; TANDEM REPEAT;

ADULT; AMINO ACID SUBSTITUTION; ARABS; AUTOANTIBODIES; BLOOD GLUCOSE; DIABETES, GESTATIONAL; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; INSULIN; ISOENZYMES; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; SCANDINAVIA;

EID: 2942628072     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-004-1388-5     Document Type: Article

References (52)

1. Metzger BE, Coustan DR, the Organizing Committee (1998) Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 21 [Suppl 2]:B161-B167
2. Buchanan TA, Metzger BE, Freinkel N, Bergman RN (1990) Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol 162:1008-1014
3. Ryan EA, O'Sullivan MJ, Skyler JS (1985) Insulin action during pregnancy. Studies with the euglycemic clamp technique. Diabetes 34:380-389
4. Hadden DR (1985) Geographic, ethnic, and racial variations in the incidence of gestational diabetes mellitus. Diabetes 34 [Suppl 2]:8-12
5. Yue DK, Molyneaux LM, Ross GP, Constantino MI, Child AG, Turtle JR (1996) Why does ethnicity affect prevalence of gestational diabetes? The underwater volcano theory. Diabet Med 13:748-752
6. Aberg A, Rydhstroem H, Frid A (2001) Impaired glucose tolerance associated with adverse pregnancy outcome: a population-based study in southern Sweden. Am J Obstet Gynecol 184:77-83
7. El-Shafei AM, Bashmi YA, Beischer NA, Henry OA, Walstab JE (1989) Incidence and severity of gestational diabetes in Bahrain and Australia. Aust NZ J Obstet Gynaecol 29:204-208
8. Agarwal MM, Hughes PF, Punnose J, Ezimokhai M, Thomas L (2001) Gestational diabetes screening of a multiethnic, high-risk population using glycated proteins. Diabetes Res Clin Pract 51:67-73
9. Mohammed N, Dooley J (1998) Gestational diabetes and subsequent development of NIDDM in aboriginal women of northwestern Ontario. Int J Circumpolar Health 57: 355-358
10. Damm P (1998) Gestational diabetes mellitus and subsequent development of overt diabetes mellitus. Dan Med Bull 45:495-509
11. Martin AO, Simpson JL, Ober C, Freinkel N (1985) Frequency of diabetes mellitus in mothers of probands with gestational diabetes: possible maternal influence on the predisposition to gestational diabetes. Am J Obstet Gynecol 151:471-475
12. Pettitt DJ, Bennett PH, Saad MF, Charles MA, Nelson RG, Knowler WC (1991) Abnormal glucose tolerance during pregnancy in Pima Indian women. Long-term effects on offspring. Diabetes 40 [Suppl 2]:126-130
13. Ellard S, Beards F, Allen LI et al. (2000) A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria. Diabetologia 43:250-253
14. Chen Y, Liao WX, Roy AC, Loganath A, Ng SC (2000) Mitochondrial gene mutations in gestational diabetes mellitus. Diabetes Res Clin Pract 48:29-35
15. Yanagisawa K, Uchigata Y, Sanaka M et al. (1995) Mutation in the mitochondrial tRNA(leu) at position 3243 and spontaneous abortions in Japanese women attending a clinic for diabetic pregnancies. Diabetologia 38:809-815
16. Festa A, Krugluger W, Shnawa N, Hopmeier P, Haffner SM, Schernthaner G (1999) Trp64Arg polymorphism of the beta3-adrenergic receptor gene in pregnancy association with mild gestational diabetes mellitus. J Clin Endocrinol Metab 84:1695-1699
17. Rissanen J, Markkanen A, Karkkainen P et al. (2000) Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin. Diabetes Care 23:70-73
18. Ober C, Xiang KS, Thisted RA, Indovina KA, Wason CJ, Dooley S (1989) Increased risk for gestational diabetes mellitus associated with insulin receptor and insulin-like growth factor II restriction fragment length polymorphisms. Genet Epidemiol 6:559-569
19. Allan CJ, Argyropoulos G, Bowker M et al. (1997) Gestational diabetes mellitus and gene mutations which affect insulin secretion. Diabetes Res Clin Pract 36:135-141
20. Alevizaki M, Thalassinou L, Grigorakis SI et al. (2000) Study of the Trp64Arg polymorphism of the beta3-adrenergic receptor in Greek women with gestational diabetes. Diabetes Care 23:1079-1083
21. Redondo MJ, Fain PR, Eisenbarth GS (2001) Genetics of type 1A diabetes. Recent Prog Horm Res 56:69-89
22. Freinkel N, Metzger BE, Phelps RL et al. (1985) Gestational diabetes mellitus. Heterogeneity of maternal age, weight, insulin secretion, HLA antigens, and islet cell antibodies and the impact of maternal metabolism on pancreatic B-cell and somatic development in the offspring. Diabetes 34 [Suppl 2]:1-7
23. Fuchtenbusch M, Ferber K, Standl E, Ziegler AG (1997) Prediction of type 1 diabetes postpartum in patients with gestational diabetes mellitus by combined islet cell autoantibody screening: a prospective multicenter study. Diabetes 46:1459-1467
24. Bennett ST, Todd JA (1996) Human type 1 diabetes and the insulin gene: principles of mapping polygenes. Annu Rev Genet 30:343-370
25. Ong KK, Phillips DI, Fall C et al. (1999) The insulin gene VNTR, type 2 diabetes and birth weight. Nat Genet 21:262-263 (Letter)
26. Waterworth DM, Bennett ST, Gharani N et al. (1997) Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome. Lancet 349:986-990
27. Bell GI, Selby MJ, Rutter WJ (1982) The highly polymorphic region near the human insulin gene is composed of simple tandemly repeating sequences. Nature 295:31-35
28. Vafiadis P, Bennett ST, Colle E, Grabs R, Goodyer CG, Polychronakos C (1996) Imprinted and genotype-specific expression of genes at the IDDM2 locus in pancreas and leucocytes. J Autoimmun 9:397-403
29. Pugliese A, Zeller M, Fernandez A Jr et al. (1997) The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 15:293-297
30. Altshuler D, Hirschhorn JN, Klannemark M et al. (2000) The common PPARgamma Pro 12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26:76-80 (Letter)
31. Van den Ouweland JM, Lemkes HH, Ruitenbeek W et al. (1992) Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1:368-371
32. Sjoroos M, Iitia A, Ilonen J, Reijonen H, Lovgren T (1995) Triple-label hybridization assay for type-1 diabetes-related HLA alleles. Biotechniques 18:870-877
33. Bennett ST, Lucassen AM, Gough SC et al. (1995) Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet 9:284-292
34. Grubin CE, Daniels T, Toivola B et al. (1994) A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37:344-350
35. Verge CF, Stenger D, Bonifacio E et al. (1998) Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes Combinatorial Islet Autoantibody Workshop. Diabetes 47:1857-1866
36. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
37. Phillips DI, Clark PM, Hales CN, Osmond C (1994) Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med 11:286-292
38. Jensen CC, Cnop M, Hull RL, Fujimoto WY, Kahn SE, American Diabetes Association GENNID Study Group (2002) Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S. Diabetes 51:2170-2178
39. Tuomilehto J, Zimmet P, Mackay IR et al. (1994) Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. Lancet 343:1383-1385
40. Petersen JS, Dyrberg T, Damm P, Kuhl C, Molsted-Pedersen L, Buschard K (1996) GAD65 autoantibodies in women with gestational or insulin dependent diabetes mellitus diagnosed during pregnancy. Diabetologia 39:1329-1333
41. Mitchell ML, Hermos RJ, Larson CA, Palomaki GE, Haddow JE (2000) Prevalence of GAD autoantibodies in women with gestational diabetes: a retrospective analysis. Diabetes Care 23:1705-1706 (Letter)
42. Dozio N, Beretta A, Belloni C et al. (1997) Low prevalence of islet autoantibodies in patients with gestational diabetes mellitus. Diabetes Care 20:81-83
43. Fallucca F, Tiberti C, Torresi P et al. (1997) Autoimmune markers of diabetes in diabetic pregnancy. Ann 1st Super Sanita 33:425-428
44. Weng J, Ekelund M, Lehto M et al. (2002) Screening for MODY mutations, GAD antibodies, and type 1 diabetes-associated HLA genotypes in women with gestational diabetes mellitus. Diabetes Care 25:68-71
45. Walsh EC, Mather KA, Schaffner SF et al. (2003) An integrated haplotype map of the human major histocompatibility complex. Am J Hum Genet 73:580-590
46. Ferber KM, Keller E, Albert ED, Ziegler AG (1999) Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes. J Clin Endocrinol Metab 84:2342-2348
47. World Health Organization Ad Hoc Diabetes Reporting Group (1992) Diabetes and impaired glucose tolerance in women aged 20-39 years. World Health Stat Q 45:321-327
48. Kadiki OA, Gerryo SE, Khan MM (1988) Diabetes mellitus in Benghazi. J Trop Med Hyg 91:19-22
49. Eriksson J, Forsen B, Haggblom M, Teppo AM, Groop L (1992) Clinical and metabolic characteristics of type 1 and type 2 diabetes: an epidemiological study from the Narpes community in western Finland. Diabet Med 9:654-660
50. Deeb SS, Fajas L, Nemoto M et al. (1998) A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20:284-287
51. Hara K, Okada T, Tobe K et al. (2000) The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun 271:212-216
52. Litou H, Anastasiou E, Thalassinou L, Sarika HL, Philippou G, Alevizaki M (2002) Increased prevalence of VNTR III of the insulin gene in women with Gestational Diabetes Mellitus (GDM). Diabetologia 45 [Suppl. 2]: A132 (Abstract)